Golimumab

Golimumab is a drug that is injected once a month to treat the symptoms of ankylosing spondylitis, rheumatoid arthritis, and psoriatic arthritis. Common side effects of this product include high blood pressure and skin redness at the injection site. Before using this medication, let your healthcare provider know if you have congestive heart failure, diabetes, cancer, or any infections.

Interested in a Discount on Golimumab?

Enter your email address to see if eMedTV's free DiscountRx service has a program that could help you save on your prescription(s).

Enter Your Email Address
 

Thank you!

Thank you for your interest in DiscountRx from eMedTV. An email has been sent to the address you provided. Please follow the link within that email to see what offers may be available.

What Is Golimumab?

Golimumab (Simponi™) is a prescription medication approved to treat the following conditions:
 
It is injected just under the skin once a month.
 
(Click What Is Golimumab Used For? for more information on this topic, including possible off-label uses.)
 

Possible Side Effects

Just like any medicine, golimumab may cause side effects. However, not everyone who takes the drug will experience problems. In fact, most people tolerate it quite well.
 
If side effects do occur, in most cases, they are minor and either require no treatment or can be treated easily by you or your healthcare provider. Serious reactions are less common.
 
Some of the most common side effects seen with golimumab include:
 
(Click Side Effects of Golimumab to learn more, including potentially serious side effects you should report immediately to your healthcare provider.)
 

Golimumab Drug Information

Referring Pages:
Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2013 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.